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Abstract.  The mammalian bladder epithelium 
elaborates, as a terminal  differentiation product, a 
specialized plasma membrane called asymmetric unit 
membrane (AUM) which is believed to play a role in 
strengthening  and stabilizing the urothelial apical sur- 
face through its interactions with an underlying 
cytoskeleton. Previous studies indicate that the outer 
leaflet of AUM is composed of crystalline patches of 
12-nm protein particles,  and that bovine AUMs con- 
tain three major proteins:  the 27- to 28-kD uroplakin 
I, the 15-kD uroplakin H and the 47-kD uroplakin Ill. 
As a  step towards elucidating the AUM structure and 
function,  we have cloned the cDNAs of bovine uro- 
plakin I (UPI). Our results established the existence of 
two isoforms of bovine uroplakin I: a 27-kD uroplakin 
Ia and a 28-kD uroplakin Ib. These two glycoproteins 
are closely related with 39%  identity in their amino 
acid sequences.  Hydropathy plot revealed that both 
have four potential transmembrane  domains (TMDs) 
with connecting loops of similar length.  Proteolytic 
digestion of UPIa inserted in vitro into microsomal 
vesicles suggested that its two main hydrophilic loops 
are exposed to the luminal  space, possibly involved in 
interacting  with the luminal domains of other uro- 
plakins to form the 12-nm protein particles.  The 
larger loop connecting TMD3 and TMD4 of both 
UPIa and UPIb contains six highly conserved cysteine 
residues;  at least one centrally located cysteine doublet 
in UPIa is involved in forming intramolecular disulfide 
bridges. The sequences of UPIa and UPIb (the latter 
is almost identical to a hypothetical, TGF/3-inducible, 
TI-1 protein of mink lung epithelial cells) are homolo- 
gous to members of a  recently described family all 
possessing four transmembrane  domains (the "4TM 
family"); members of this family include many impor- 
tant leukocyte differentiation markers such as CD9, 
CD37, CD53, and CD63.  The tissue-specific and 
differentiation-dependent expression as well as the nat- 
urally occurring crystalline state of uroplakin I mole- 
cules make them uniquely suitable, as prototype mem- 
bers of the 4TM family, for studying the structure and 
function of these integral membrane proteins. 
T 
HE asymmetric unit membrane (AUM) ~ is a unique 
plasma membrane elaborated as a major differentia- 
tion product of the mammalian urothelium which lines 
the surfaces of renal pelvis, ureter, bladder, and urethra (Por- 
ter and Bonneville,  1963; Porter et al., 1967; Hicks, 1975). 
It forms numerous plaques covering the apical surface of the 
superficial  cells of the multi-layered  urothelium.  The name 
AUM reflects the fact that its outer leaflet is almost twice as 
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1.  Abbreviations  used in  this paper:  AUM, asymmetric unit membrane; 
CNBr, cyanogen bromide; 4TM, four transmembrane domain; KLH, key- 
hole  limpet  hemocyanin;  MBS,  m-maleimidobenzol-N-hydroxysueeini- 
mide; TMD,  transmembrane domains; UPI-III, uroplakin I-III. 
thick as its inner one (Hicks, 1965; Koss, 1969; Pauli et al., 
1983). The thickened outer leaflet is composed of crystalline 
patches of 12-nm particles,  each of which consists of six in- 
ner and six outer domains (Hicks and Ketterer,  1969; Ver- 
gara et al.,  1969; Hicks and Ketterer,  1970; Knutton and 
Robertson,  1976; Robertson and Vergara,  1980).  Morpho- 
logical and physiological  studies suggest that AUM may be 
involved in strengthening  and stabilizing  the urothelial  cell 
surface, possibly through its interactions  with an underlying 
cytoskeleton, thus preventing  the cells from rupturing  dur- 
ing bladder distention  (Staehelin  et al.,  1972; Minsky and 
Chlapowski,  1978; Lewis and deMoura, 1984; Sarikas and 
Chlapowski,  1986).  We  have  recently  demonstrated  that 
highly  purified  bovine AUM plaques,  when analyzed  by 
SDS-PAGE, yielded three major protein bands in the molec- 
ular weight ranges  of 47, 27 to 28, and  15 kD (Wu et al., 
1990).  Antibodies have been raised against  these proteins 
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trastructural level that they are all AUM-associated in situ 
(Wu et al.,  1990).  Based on their established association 
with the AUM of urothelial plaques, we named these pro- 
teins uroplakin I (27 to 28 kD), uroplakin II (15 kD), and 
uroplakin HI (47 kD). 
In this paper, we have chosen to study the 27- to 28-kD 
uroplakin I (UPI) which has been identified as a major pro- 
tein component of not only bovine AUMs, but also AUMs 
of pig, sheep, and rat (Ketterer et al., 1973;  Vergara et al., 
1974; Caruthers and Bonneville, 1977; Stubbs et al., 1979; 
Wu et al.,  1994).  We have previously raised a monoclonal 
antibody (AE31) and several polyclonal antisera to this com- 
ponent. The AE31 monoclonal antibody recognizes a 27-kD 
protein which was shown by EM to be associated with the 
outer leaflet of urothelial apical AUMs (Yu et al.,  1990). 
Immnno-affmity  chromatography using this antibody yielded, 
in one step,  the corresponding 27-kD  antigen, which co- 
purified with UPII and UPHI most likely through specific 
protein interactions (Yu et al., 1990).  In an independent ex- 
periment, we generated antisera against all the uroplakins by 
immunizing rabbits with native bovine AUMs. Antibodies to 
UPI  were affinity-purified from these anti-AUM antisera 
using the electrophoretically purified 27- to 28-kD compo- 
nent. These affinity-purified antibodies recognized specifi- 
cally a 28-kD protein band by immunoblotting, and again 
decorated the outer leaflet of apicai AUMs (Wu et al., 1990; 
1994). However, these polyclonal antibodies failed to recog- 
nize the AE31-purified 27-kD  component (Wu,  X.-R., un- 
published observation). Moreover, we have recently found 
that although the 27 to 28-kD component of bovine AUMs 
appear as a  broad band on SDS-PAGE,  that of the rabbit 
AUMs can be resolved into two weft-defined bands (Wu et 
al., 1994).  Taken together, these data strongly suggest that 
the 27- to 28-kD component of bovine AUMs, previously 
thought to consist of only one protein, is heterogeneous. 
To address the issue of heterogeneity and to enhance our 
understanding on how this major 27- to 28-kD AUM compo- 
nent may participate in the formation of the 12-nm protein 
particles, we have set out to clone its cDNA. We describe 
here the cloning and characterization of two types of bovine 
UPI cDNAs, one encoding Uroplakin Ia- a 27-kD glycopro- 
tein, and another encoding uroplakin Ib-a 28-kD glycopro- 
rein. These two proteins are 39%  identical in their amino 
acid sequences and both contain four potential transmem- 
brane domains (TMDs). Studies on the proteolytic digestion 
of uroplakin Ia inserted in vitro into dog pancreatic micro- 
somes suggest that its two hydrophilic loops interconnecting 
TMDs  1/2 and TMDs 3/4 are exposed to the luminal (ex- 
oplasmic; exo)  space possibly involved in interacting with 
the luminal portions of other uroplakins to form the 12-nm 
protein particles. Very little cytoplasmic (cyto) domains ex- 
ist for UPIa and Ib.  Thus, like UPII and HI, the two uro- 
plakin I molecules have an extremely high ratio of Mass~/ 
Mass~,o. Such a highly asymmetric mass distribution of all 
the major AUM protein subunits may contribute to the thick- 
ened appearance of the outer leaflet of AUM. Finally, we 
present evidence that uroplakins Ia and Ib share significant 
sequence  homology with  a  recently described  family of 
membrane proteins called the "four transmembrane domain" 
(4TM) family. Members of this gene family include several 
important leukocyte differentiation markers such as CD9, 
CD37,  CD53, and CD63.  The tissue-specific and differen- 
tiation-dependent expression  and the  naturally occurring 
crystalline state of uroplakins Ia and Ib make them ideally 
suitable, as prototype members of this family, for studying 
the  expression,  structure  and  function  of  these  unique 
plasma membrane molecules. 
Materials and Methods 
Amino Acid Sequencing 
Bovine AUMs were purified by sucrose density gradient centrifugation as 
described (Wu et al., 1990). The AUM protein components (without prior 
reduction) were separated by SDS-PAGE (15% acrylamide), and then trans- 
ferred electrophoretically  to lmmobilon-PVDF  membrane (Millipore,  Bed- 
ford, MA) and stained with Coomassie blue. The 27- to 28-kD protein band 
corresponding to uroplakin I was excised and subjected to NH2-terminal 
amino acid sequencing.  For generating internal sequences,  the electropho- 
retically purified 27- to 28-kD protein was digested by cyanogen bromide 
(CNBr) or trypsin (Linet al.,  1994). The CNBr-peptide fragments were 
resolved by SDS-PAGE (16.5 % acrylamide, 6 % bisacrylamide) in a Tricine 
buffer (Schagger and yon Jagow, 1987), while the tryptic pepfides were frac- 
donated by reverse phase HPLC.  The NH2-terminal  sequences of all the 
major, well-resolved  peptide bands or peaks were determined. Automatic 
amino acid sequencing  was performed using an ABI model 477A protein 
sequencer (courtesy  of William Lane, Harvard Microchemistry Facility, 
Cambridge,  MA). 
Polymerase Chain Reaction and Screening 
of  cDNA Library 
Total RNAs were isolated form bovine  tissues and cultured bovine  urothelial 
cells (Sambrook et al.,  1989), and poly(A)+ mRNAs ware purified using 
an oligo-dT  cellulose column (type 3; Collaborative Research,  Boston, 
MA). Single-stranded cDNAs of these mRNA were synthesized using avian 
myoblastosis  virus reverse  transcriptase (Promega,  Madison,  WI)  and 
oligo-dT primers. Degenerate oligonucleotide primers in both sense and an- 
tisense orientations ware synthesized based on three partial amino acid se- 
quences: PEVVFP,  MLTFYS,  and DYLFTK  as indicated in Fig.  2.  To 
facilitate the subeloulng of the PCR products, additional HindIII and EcoRI 
linkers were placed on the 5'-end of the sense and anlisense primers, respec- 
tively. PCRs were performed with ~  polymerase (Perkin-Elmer Cetus, 
Norwalk,  CT)  using bovine liver or  bladder epithelial  single-stranded 
cDNA as the template.  30 thermal cycles were performed, each consisting 
of dennturation at 94°C for 1 rain, annealing at 55°C for 1 min, and exten- 
sion at 72°C for 1 rain. The PCR products were resolved in a 1.5% agarose 
gel. Selected bands were eluted, subcloned into pGEM-72 (Promega Bin- 
tec,  Madison, WI) and sequenced using a T7 DNA Sequencing  Kit (Ver- 
sion 2; US Biochemical, Cleveland, OH). Specific PCR products were 32p. 
labeled and used to screen a kgtl0 cDNA library of bovine bladder epithe- 
lium (Lin et al.,  1994). Hybridization was carried out at 60°C overnight 
in a solution containing 6× SSC, 5 × Denhardi's solution,  1% SDS, and 100 
~tg/ml of denatured salmon sperm DNA. cDNA inserts from positive phage 
were subcloned into pGEM7Z and sequenced.  The immunological screen- 
ing of a kgtl 1 expression library was done according to standard methods 
(Sambrook et al.,  1989). The cDNA inserts of positive clones were sub- 
cloned into pGEM3Z and sequenced in both strands. 
Northern Blot Analysis 
20/zg  of  total  cellular  RNAs were  fractionnted  on  a 1% agarose  gel  contain- 
ing formamide, and transferred  onto a nylon filter  (Hybond;  Amersham 
Corp., Arlington Heights,  I-L).  The blot  was hybridized  with 32p-labeled 
UPla or UPIb cDNA at  42°C overnight  in 6× SCC, 50% formamide, Ix 
Denhardt's  solution,  0.1% SDS, 10% dextran,  0.I M  EDTA, and 50/tg/mi 
denatured  salmon sperm DNA. The filter  was  then  washed at  65°C in  0.2× 
SCC and 0.1% SDS for  30 min. In some cases,  the  probe was stripped  off 
by washing the filter  in  50% formamide and 2× SCC at  80°C for I  h fol- 
lowed by rehybridizing  with a 32p-labeled  human/3-actin cDNA. 
Primer Extension Assay 
Primer extension was carried out using a kit from Promega Biotec. Three 
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synthesized based on uncleotide sequences complementary  to nucleotides 
195-219,  102-126, and 75-91 of UPIa cDNA, respectively (see Fig. 4). A 
32p-labeled primer (0.5 pmole) was annealed with 10/~g of  total RNA from 
bovine liver, bladder epithelium  or cultured  urothelial  cells,  and  reverse 
transcribed at 42°C for 30 rain. The extended products were then analyzed 
on an 8% DNA sequencing gel. The size ladder was generated from a con- 
trol M13 template  and a forward primer using a T7 Sequenase Kit. 
Generation of  Antibodies Against Synthetic Peptides 
Tt~3 peptides, 93SNQGRELTRLWDI~ and  "AKDDSTVRSFQGT.Ln~GN; 
were chemically synthesized  (courtesy of Dr. William Lane) based on the 
cDNA-derived amino acid sequences of UPIa and UPIb, respectively (Figs. 
4 and 5). An additional cysteine residue was placed at the COOH terminus 
of each peptide to facilitate the conjugation to the carrier proteins. The un- 
derlined serine residue of the UPIb peptide replaced an original cysteine to 
avoid excessive cross-linking. These two peptides were crosslinked to key- 
hole limpet hemocyauln (KLH) or bovine serum albumin using m-male- 
imidobenzul-N-hydroxysuccinimide (MBS). 100/~g of the conjugated pep- 
tide were used to immunize each rabbit for the primary injection, and 50/~g 
for booster  injections at 2-wk intervals. 
rain. The membrane mixtures were then incubated with endoglycosidase H 
in a citrate buffer (150 mM sodium citrate, pH 6.0, 0.2% SDS,  1% octyl 
glucoside and 2 mM PMSF) or with N-glycosidase F (Boehringer Mann- 
heim Biochemieals) in a phosphate buffer (50 mM sodium phosphate, pH 
7.5, 0.1% SDS,  1% octyl glucoside,  and 2 rnM PMSF).  After incubation 
at 37°C for 16 h, the reaction mixtures were resolved by SDS-PAGE and 
electrophoretically  blotted onto a nitrocellulose filter. In some cases, pro- 
teius were reduced with 5 % ~-mercaptoethanol before loading onto the gel. 
UPIa and  UPIb were detected by Western blot analysis  (Eichner  et al., 
1984) using antisera  against synthetic peptides unique to each UPI. 
Sequence Analysis 
The nucleotide and the deduced amino acid sequences of UPIa and UPIb 
were  compared  with  the entries  in GenBank,  EMBL, PIR-Protein,  and 
SwissProt data bases through FASTA  or TFASTA algorithms (GCG7 pack- 
age; University of Wisconsin, Madison, WI). The secondary structures of 
proteins  were predicted  by the PEPTIDESTRUCTURE program  (GCG7 
package) or GeneWorks 2.0 (lntelliGenedcs,  Inc., Mountain  View, CA). 
Multiple  sequence  alignment  was  carried  out  using  the  LINEUP and 
PILEUP programs  (GCG'/package). 
In Vitro Translation and Microsome Insertion Assay 
The UPIa cDNA, subcloned in pGEM7Z, was used to transcribe in vitro 
capped  mRNA using a Riboprobe  Kit (Promega Biotec) and m7G(5')ppp 
(53G (Pharmacia Fine Chemicals, Piseataway, NJ). Translation in the pres- 
ence and  absence  of dog pancreatic  microsomes  was  performed  using 
[3SS]methionine in a rabbit reticulocyte lysate system (Promega Biotec) as 
described  (Linet al.,  1994). For deglycosylation assays, the translation 
products  were boiled in 1% SDS for 3 win, and then incubated with 100 
mU/wi of endoglycosidase H (Boehringer Mannheim Biochemicals, Indi- 
anapolis,  IN) in 150 mM sodium citrate (pH 6.0), 0.2% SDS, and 2 mM 
PMSF at 37°C overnight. For protease protection assays, a mixture of tryp- 
sin and chymotrypsin was added to a final concentration of 100 ~g/ml. The 
digestion was performed on ice for 1 h and terminated by adding a protease 
inhibitor, leupeptin. In some experiments, Triton X-100 was added to a final 
concentration of 0.5 % to solubilize the microsome vesicles before protease 
digestion. All the above translation products were analyzed by SDS-PAGE 
on a 15% gel and autoradiographed. 
Deglycosylation and Western Blot Analysis 
Bovine AUMs were solubilized in 0.5% SDS at room temperature  for 15 
Results 
Isolation of  cDNAs Encoding Two Closely  Related 
Uroplakin I Molecules 
Taking advantage  of the extreme insolubility  of AUMs in a 
broad spectrum of detergents,  we have previously devised a 
way for isolating  large amounts  of bovine AUMs using su- 
crose density gradient centrifugation  followed by dissolving 
the  non-AUM  contaminating  membranes  in  deoxycholate 
OVu et al.,  1990). Such highly purified AUMs are morpho- 
logically intact exhibiting crystalline patches of 12-nm pro- 
tein particles, which contain three major protein bands when 
analyzed by SDS-PAGE (Fig.  1 a, lane 2). We sequenced the 
NH2 terminus  of the 27- to 28-kD protein and obtained a 
mixture of two sequences (Fig.  2). To generate additional, 
internal  sequences,  we digested the electrophoretically puri- 
fied 27- to 28-kD uroplakin I protein (Fig.  1 a, lane 3) with 
b.  mAU 
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Figure  1.  Isolation  of CNBr 
and tryptic peptides of bovine 
27- to 28-kD uroplakin I.  (a) 
Electrophoretic  separation  of 
bovine  uroplakins.  AUMs 
were  purified  from  bovine 
bladder  epithelium  and  the 
three  major  uroplakins  (I, 
II,  and  HI)  were  resolved, 
without  prior  reduction, 
by  preparative  Tricine/SDS- 
PAGE  (lane  2).  The  protein 
markers (lane 1) have molec- 
ular masses of 66, 45,  36, 29, 
24, 20,  17,  14, 8, 6.2, and 2.5 
kD (dotted from top to  bot- 
tom).  The 27- to 28-kD  UPI 
band  was  electrophoretically 
purified (lane 3), cleaved with 
cyanogen  bromide  (CNBr), 
and  again  resolved  elec- 
tropboreticaily  without  prior 
reduction 0ane 4).  Note the clear resolution of two major CNBr fragments C1  and C2 (lane 4).  (b) Tryptic peptides.  The 27- to 28-kD 
UPI protein was electrophoretically transferred  from a preparative SDS polyacrylamide gel onto a nitrocellulose filter, and digested in 
situ with trypsin. The released peptide fragments were separawxt by reverse phase HPLC, and the NH2-terminal sequences of the peptides 
of the two major peaks  (T1 and  T2) were determined. 
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(1)C1  (DIL)-tTIB)-ilrlV)-Y-tSlY)-tTIA)-(glD)-CAIB)-trlN)-(~IQ)-(AIO)-(T/Z)- 
(2) C2  (Z/D) - (E/W) - (Q/V) -E-F-T-  (SlO) -A-P-R-A-T-T-P-R-V-V-F-P- 
(3)  T~  (D/Q) - (M/Y) - (L/M} - (V/T) - (F/S) - (Y/N) - (S/P} - (A/S) - (D/L)- (S/I) - (N/T) - 
(OIK) -G- 
(4)  T2  (Q/L) - [M/G) - (L/H) - (T/L) ~ (F/D) -Y-L-F-T-K 
(5)  NH 2  (D/A) - (I(/F)  -D- (D/~) -S- (W/T) - (V/L) - (R/S) -G- (L/F) - (L/Q) - (S/G} - (P/L) - 
(V/L} - (M/Z) - (F/T) - (G/E) - (N/L) -V- (Z/L) ~ 
B. Deduced Sequences: 
#I Cl and C2  D- (E) -V-?  -,-,-,-.-,-,-.-,-,-,-,-.-.-,-,- 
I 
Cl orily  L-T-P  -Y-S -A-D- 8-N-0-G-  I- 
#~ C2 only  ~- (W) -Q-E-?~?-G  - 
#4 T1, T2 and #2  9-M- L-T-F-Y-S-A-D-S-N-O-G- 
2 
#5 T1 only  D-Y-X-V-S-N-P-8-L-I-T-K 
#51"2 only  L-G-H-L-D-Y-L-~-T-  3 
Figure  2. Partial amino acid sequences of bovine 27- to 28-kD uro- 
plakin I. (,4) Primary data showing the original partial amino acid 
sequences generated by automatic  sequencer. C1 and C2 are the 
NH2-terminal sequences of two CNBr-peptides (Fig. 1 a); T1 and 
T2 are NH2-terminal sequences of two tryptic peptides (Fig. 1 b); 
while NH2 represents the NH2-terminal sequences of electropho- 
reticaUy purified, intact 27- to 28-kD protein. All amino acids are 
represented by single letter codes. In many cases two amino acids 
were  identified from one cycle of Edman  sequencing;  these two 
amino acids are listed in a parenthesis. (B) The amino acid residues 
shared by C1 and C2 peptides (plus the remaining COOH-terminal 
C2 sequence) are shown as "#1  ~ sequence. Subtraction of this se- 
quence from C1 and C2 sequences yielded the "#'F and "#Y se- 
quence, respectively. Amino acids shared by T1 and T2 (as well as 
the "#2" sequence) are listed as "#4" sequence. Subtraction of this 
sequence from T1 and I2 sequences gave rise to "#5" and "#6" se- 
quences,  respectively. The two amino acid assignments in paren- 
theses were ambiguous and were later found to be erroneous  ac- 
cording to eDNA data.  "?." indicates uncertainty.  From the three 
underlined sequences (1 to 3), degenerate oligonucleotide primers 
were synthesize in both sense and antisense directions  and were 
used to amplify the cDNAs of UPI by PCR. 
cyanogen bromide yielding two major peptides (el and C2; 
Fig.  1 a, lane 4).  In addition,  we trypsinized UPI and iso- 
lated two major tryptic peptides of uroplakin I  by reverse 
phase HPLC (T1 and "1"2; Fig.  1 b). The NH2-terminal se- 
quences of all the above peptides, most of them containing a 
mixture of two sequences, are listed in Figure 2 A. Based on 
the fact that C1 and C2 sequences contain an overlapping se- 
quence D-(E)-V-?-F-T-etc (Fig. 2 B, sequence/), we deduced 
two other sequences by subtraction (Fig. 2 B, sequences 2 
and 3). Similarly, from the two "double" sequences of T1 and 
"I2 we were able to deduce three sequences (Fig.  2  B,  se- 
quences 4-6). 
Based on  some of these amino acid  sequences,  we de- 
signed three degenerate oligonucleotide primers to perform 
PCR using the cDNAs of  bovine bladder epithelium and liver 
as the templates (Fig.  3 a, and data not shown).  Only one 
particular  combination  of these  primers (2~3)  yielded  a 
bladder-specific PCR product of about 270 bp in length (Fig. 
3  a, lane/).  When this product was cloned and used as a 
probe for Northern blot analysis, a  1.5-kb mRNA was de- 
tected in bovine bladder (Fig. 3 b, lane/) but not in the liver 
(lane 2).  Using this partial eDNA as a probe, we screened 
a bovine urothelial eDNA library and obtained eight clones 
containing  overlapping cDNAs.  The combined nucleotide 
sequence of these clones and its corresponding amino acid 
sequence are shown in Fig. 4. This eDNA sequence (1,363-bp 
Figure 3. Generation of a sequence- and urothelium-specific partial 
DNA of bovine uroplakin  I  (UPI) by PCR.  (a) PCRs were per- 
formed  using  different combinations  of oligonueleotide  primers 
(marked 1 to 3, Fig. 2 B) in both directions. The templates were 
eDNA of either bovine bladder epithelium 0ane I  and 3) or liver 
(lane 2 and 4), and the products were resolved electrophoretically 
and  stained  with  ethidium  bromide.  Only  one  combination  of 
primers  consisting  of sense  primer  2  and  antisense  primer  3 
("2~3  ") yielded  a urothelium-specific PCR product  of '~ 270 bp 
(asterisk; a, lane 1). The upper part of b is a Northern blot showing 
that this 270-bp bladder-specific  PCR product  detected  a  1.5-kb 
mRNA in bovine urothelium (lane 1 ) but not in liver (lane 2); the 
lower part shows the detection  of/~-actin mRNA as an internal 
control. 
long) contains a short 5'-untranslated sequence of 18 bp, a 
single open reading frame of 774 bp, followed by a 571  bp 
of 3"untranslated region containing a  polyadenylation sig- 
nal, The open reading frame encodes a polypeptide of 258 
amino acids which can account for all six partial, internal 
amino acid sequences of the 27- to 28-kD uroplakin I protein 
listed in Fig.  2  B.  However, it cannot account for the two 
NH2-terminal  sequences.  Although  the  predicted  initiator 
methionine is in a context favorable for translation initiation 
(Kozak, 1984) and the length of the eDNA is close to that 
of the corresponding mRNA (Fig.  3 b), we performed sev- 
eral experiments to test the possibility of an incomplete 5' se- 
quence.  Primer extension assays were done using an inde- 
pendent batch of bovine urothelial cDNA as the template. 
Three different primers (see Materials and Methods) yielded 
extension products terminating at the same 5' end of the ex- 
isting eDNA (data not shown). Similarly, using the 5' RACE 
(rapid amplification of eDNA end) approach (Frohman et 
al.,  1988) we failed to generate additional sequences beyond 
the 5' end of our current eDNA clones. These results strongly 
suggest that the unaccounted for NH2 terminal sequences of 
the intact 27- to 28-kD uroplakin I are due to other proteins. 
To clone these other uroplaldn I molecules, we tried sev- 
eral approaches including the immunoscreening of a cDNA 
expression library.  We have previously immunized rabbits 
with intact bovine AUMs containing all uroplakins (see In- 
troduction). Antibodies to the 27- to 28-kD uroplaldn I were 
affinity purified and used to screen a kgtl 1 expression library 
of bovine urothelial  cells.  An  ensuing  positive clone was 
used to re-screen the library. Several partially overlapping 
clones  were obtained,  and  their  combined nucleotide  se- 
quence along with its theoretically translated amino acid se- 
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of bovine uroplakin Ia (UPIa). The stretches of deduced amino acid 
sequences which match with protein microsequencing data are un- 
derlined and numbered according to Fig. 2 B; inconsistencies are 
underlined by dashes.  Four stretches of hydrophobic amino acids 
that are long enough to span the lipid bilayer are boxed and shaded. 
A potential N-linked glycosylation site is circled, and the polyade- 
nylation signal near the poly(A) tail is underlined by a thick bar. 
Figure 5.  The deoxynucleotide and deduced amino acid sequence 
of bovine uroplakin lb (UPIb). The deduced NH2-terminal amino 
acid sequence (underlined) matches one of the two NH2-terminal 
sequences of 27- to 28-kD UPI. The N-linked glycosylation site is 
circled, and the putative polyadenylation signal AATAAA is under- 
lined by a thick bar.  The dash-underlined  3'-untranslated region 
represents a bovine Alu-like repetitive sequence. Other symbols are 
as in Fig. 4. 
quence is shown in Fig.  5.  This  1,965-bp  cDNA  sequence 
contains  a  61-bp  5'-untranslated  sequence,  a  single  open 
reading  frame encoding a  protein of 260 amino acids,  fol- 
lowed by a relatively long 3'-untranslated region of 1,124-bp 
containing  a  bovine  Alu-like  repetitive  sequence.  The 
3'-untranslated region contains a polyadenylation signal with 
a poly (A) tail, thus establishing the intactness of the 3' end. 
Interestingly,  this  cDNA-encoded  protein  can  account  for 
one of the two  N  terminal  sequences,  i.e.,  AKDDSTVR?- 
FQGLLIFGNVI (compare Fig. 5 and sequence #5 of Fig. 2 
A).  Alignment of the amino acid  sequence  of the two uro- 
plakins showed a 39% identity in their amino acid sequences 
(Fig.  6  a),  even though  their noncoding  regions  are diver- 
gent.  Hydropathy plots  revealed that both proteins  possess 
four  stretches  of  hydrophobic  amino  acids  that  are  long 
enough to serve as TMD (Fig.  6, a  and b).  The location of 
these four TMDs in the two uroplakin I molecules is almost 
identical,  in that the first and the fourth TMDs are located 
near  the  NH2  and  COOH  terminus,  respectively.  TMD  1 
and 2 are connected by a relatively short ("~20 amino acids), 
while TMDs 3 and 4  are connected by a long ('~120 amino 
acids) hydrophilic  loop.  The longer loop of each uroplakin 
I  polypeptide  contains  a  potential  N-glycosylation  site  as 
well as six highly conserved cysteine residues.  In contrast, 
TMDs  2  and  3  are  interrupted  by an  extremely  short but 
a. 
OPlb:  I  .... KDDSTV  FV  EATN  64 
........... 
132  PNNDDQWKNNG  QD  ENSDAD  NSLK  200 
201  U  P  HE  GPMNR  FGFA  YWSRI  DY  260 
b.  c. 
....  ,~  '  '  'lob  '  '1'  ';go.  ....  ~  .... 
d.  t-"  r 
lit  I  m  mm  ....  ml 
40  B0  120  160  200  240  Ibl,m  m~m,  ~  ....  ml 
Figure 6. Sequence and structural similarities between bovine uro- 
plakins Ia and lb. (a) Alignment of the two amino acid sequences. 
Identical  amino  acid  residues  shared  by the  two  sequences  are 
boxed, and the conserved cysteine residues are marked by asterisks. 
Gaps (dotted) are introduced to maximize the homology. N-linked 
glycosylation sites are circled.  The four horizontal bars mark the 
hydrophobic,  potential transmembrane domains (see below).  (b) 
Hydropathy plot of UPIa and UPIb, done with a moving window 
of 11 amino acids (Kyte and Doolittle, 1982). (c) Homology matrix 
plot of UPIa and UPIb. Note that maximal homology exists in the 
four  hydrophobic  domains  and  in  the  middle  part  of the  long 
hydrophilic region.  (d)  Schematic sequence comparison of UPIa 
and  UPIb.  The  filled  boxes  represent  the  putative  membrane- 
spanning domains.  Three positively charged amino acids located 
between the second and third transmembrane domain are indicated 
by plus  signs.  The cysteine residues  and  N-linked glycosylation 
sites are denoted by vertical bars and circles, respectively. 
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Molecular mass (kD) 
SDS-PAGE 
Partial amino acid 
UP  sequence  Native  Core  cDNA  Anti-Ial 
Antibodies 
Anti-Fol  Anti-27/28Kl|  AE31§ 
AUM-association 
in situ 
Gene locus on 
bovine chromosome¶¶ 
Ia  All 6 internal  sequences*  271  25¶  28.89**  +  -  -  - 
lb  NH2 terminus 1,  28i  264  29.68H  -  +  +  - 
Ic  NI-I2  terminus  2*  271  19"*  ?  --  --  --  + 
? 
-t-Ill 
+§ 
18 
I 
? 
* Sequences #1  to #6 of Fig.  2  b. 
¢ Sequence (5) of Fig. 2 a. 
Yu et el. (1990). 
I Based on immunoblotting  using monospecific  antisem to synthetic peptides (Fig. 8). 
q[ Immunoblotting  after deglycosylation  (Fig, 7, lane 3; Fig. 8 b). 
** Lin et al. (unpublished). 
**cDNA data (Fig. 4). 
H  cDNA data (Fig.  5). 
II An affinity-purified  polyclonal rabbit antibody to the 27-28 kDa total UPI proteins (Wu et al., 1990). 
¶¶ Ryan et al. (1993). 
highly  charged linker region  (Fig.  6  b).  The sequence ho- 
mology and similar spatial arrangement of the TMDs of the 
two proteins indicate that they are closely related (Fig.  6, c 
and d). We therefore named them uroplakins Ia (27 kD; Fig. 
4) and Ib (28 kD; Fig. 5). The properties of uroplakin I mole- 
cules are summarized in Table I  (also see Discussion). 
Determination of the Transmembrane 
Topology of Uroplaldn Ia by In Vitro Microsomal 
Insertion Assays 
To determine the transmembrane topology of UPIa, we stud- 
ied its protease accessibility after it had been inserted in vitro 
into dog pancreatic microsomes (Fig. 7). In this experiment, 
UPIa cDNA was transcribed and translated in vitro yielding 
a primary product which migrated as a 25-kD band on SDS- 
PAGE (Fig.  7, lane 2).  Upon co-translational  insertion into 
dog pancreatic microsomes, this protein became larger ('~27 
kD; lane 4) which, however, could be converted back to its 
original size of 25 kD by deglycosylation using endoglycosi- 
dase  H  (Fig.  7,  lane  5).  This  proved that the  extra  2-kD 
equivalents of mass was due to the addition of an N-linked 
high-mannose oligosaccharide to a luminal domain of UPIa. 
Digestion of this membrane-inserted UPIa glycoprotein with 
a mixture of trypsin and chymotrypsin yielded a 26-kD gly- 
coprotein (Fig.  7, lane 6) containing a  core protein of ~  24 
kD (lane 7). In contrast,  extensive digestion of the inserted 
UPIa molecule was observed if the microsomal vesicles were 
detergent-treated  before  the  addition  of proteases  (Fig.  7, 
lane 8),  indicating  that membrane integrity  is required  for 
such a protection. These results strongly suggest that the two 
hydrophilic  loops face the microsomal lumen  (exoplasmic) 
space thereby protected from extraneously added proteases. 
According  to this model,  the NI-I2 and COOH termini and 
the short linker interconnecting  TMD2 and TMD3  (Fig.  6) 
face the cytoplasmic side and therefore should be susceptible 
to proteolytic digestion.  The fact that a 26-kD glycoprotein 
was  generated  (Fig.  7,  lane  6)  suggests  that  although  the 
NH2  and/or  COOH  termini  (totalling  1  to  2  kD)  were 
digested, the extremely short tinker region (,~5-amino acid 
residues)  was  still intact probably due to  steric hindrance 
(see below). 
Uroplakin Ia and Ib Are Distinct Glycoproteins with 
High Mannose Type of  Oligosaccharides 
The data presented so far suggest the existence of at least two 
uroplakin I polypeptides. To identify these two molecules at 
the protein level, we raised rabbit antisera against a synthetic 
peptide of 14 amino acids corresponding to a  sequence lo- 
cated  in  the  middle  of the  major  luminal  loop  of  UPIa 
(DSNQGRELTRLWDR;  residues 139 to 152; see Fig. 6 a), 
and another peptide of 18 amino acids corresponding to the 
Figure Z Proteolytic digestion of uroplakin Ia inserted in vitro into 
microsomal vesicles. In vitro transcribed uroplakln Ia mRNA was 
translated in the absence (-; lanes 1 to 3) or presence (+; lanes 
4 to 8) of dog pancreative microsomes (M). Lame I  shows a control 
with no mRNA. After the translation was completed, some samples 
were dissolved in 1% SDS and treated with endoglycosidase H (EH; 
lanes 3, 5,  7); some were digested with a mixture of trypsin and 
cbymotrypsin (P; lanes 6to 8) or protease plus endoglycosidase H 
(lane 7). Microsomal vesicles of lane 8 were solubilized in 0.5% 
Triton X-100 before the proteases were added. Note the formation 
of nascent (core) 25-103 UPIa protein (lane 2), its conversion to 
a  27-kD  glycosylated  form  of  UPIa*  (lane  4),  the  effect  of 
deglycosylation (lane 5), and the partial digestion of UPIa* by pro- 
teases resulting in the formation of a 26-kD product (lane 6) with 
a 24-kD core protein (lane 7). 
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FGN; residues to 2 to 19; Fig. 6 a). These two peptides were 
synthesized because according to cDNA sequence data they 
should be unique to the two UPIs (Fig. 6 a). We found that 
antisera against these two peptides were indeed monospecitic 
recognizing separately, in total AUM proteins, a 27-kD UPIa 
and a  28-kD  u-Pro,  which are only partially resolved by 
SDS-PAGE (Fig. 8 a; Table I). Prior treatment of  total AUM 
proteins with endoglycosidase H reduced these two proteins 
to 25 and 26 kD (Fig. 8 b), indicating that the single, poten- 
tial N-glycosylation site located in the middle of the luminal 
loop of the two uroplakin I molecules is most likely gly- 
cosylated with the high mannose type of oligosaccharides. 
An interesting difference  between UPIa and UPro, as seen 
in the above deglycosylation experiment, is that only the 
former formed a homodimer. This dimer is 54 kD; it is recog- 
nized by antibodies to UPIa but not by antibodies to UPIb, 
UPII, or UPIII (Fig. 8 b and data not shown); and it can be 
destroyed by reduction. No disnlfide-stabilized UPlb homo- 
dimer was observed, however, under comparable experimen- 
tal conditions (Fig.  8 b). 
The Expression of  Both Uroplakin Ia and Ib Is 
Urothelium Specific 
We have shown earlier using antisera to several uroplakins 
that these proteins, which are the major protein subunits of 
AUM,  are differentiation products of mammalian bladder 
epithelium (Surya et al.,  1990;  Wu et al.,  1990;  Yu et al., 
1990).  To determine whether this is true for both UTIa and 
UPIb and to decide whether the tissue-specificity  is reflected 
at the mRNA level, we probed mRNAs of various bovine 
tissues  with appropriate  cDNAs.  Abundant UPIa  and Ib 
mRNAs can be detected in bovine bladder epithelium and in 
cultured bovine urothelial cells (Fig. 9). They are undetect- 
able, however,  in esophageal epithelium, snout epithelium, 
intestinal epithelium, liver, kidney (excluding renal pelvis), 
lung,  and  brain  (Fig.  9),  thus  establishing  the  bladder 
specificity of UPIa and Ib messages. 
Discussion 
In this paper, we have established that the 27-kD component 
of bovine AUM, previously thought to consist of only one 
protein, actually contains at least two closely related mole- 
cules, the uroplakins Ia (27 kD; Fig. 4) and re (28 kD; Figs. 
5 and 6; Table I). We have also obtained information regard- 
ing the transmembrane topology (Figs. 7 and 11), the intra- 
and intermolecular disulfide cross-linking (Figs. 2, 4, and 
8), and the tissue-specific distribution of UPI messages (Fig. 
9). Finally, our data indicate that uroplakins Ia and Ib, two 
major differentiation  products of  mammalian bladder epithe- 
lium, belong to a novel family of  membrane proteins all hav- 
ing four membrane-spanning domains (Fig.  10). 
Heterogeneity of Uroplakin I 
The cDNA-deduced molecular mass of UPIa core polypep- 
tide is 28,882 D (Fig. 4) which, together with "~2 kD corre- 
sponding to the high mannose-type oligosaccharide moieties 
(Fig. 8 b), yields a theoretical molecular mass of •  31 kD. 
However, UPIa migrates as a 27-kD band on SDS-polyacryl- 
amide gels (Fig. 8 a). Such an under-estimation of the mo- 
lecular mass by SDS-PAGE has been noted before in other 
proteins that contain multiple transmembrane domains, e.g., 
the gap junction proteins (Paul, 1986; Zhang and Nicholson, 
Figure 8. Identification of uroplakins Ia and Ib in purified bovine 
AUMs by immunoblotting  using antibodies raised against synthetic 
oligopeptides. (a) Proteins of gradient-purified  bovine asymmetric 
unit membrane (AUM) were resolved by SDS-PAGE under reduc- 
ing conditions, electrophoretically  transferred onto a nitrocellulose 
sheet, and stained with Fast Green (FG). Note the resolution of  the 
27- to 28-kD UPI, the 15-kD UPII, and the 47.kD UPIR. Similar 
sheets were stained immunochemically with an antiserum a oainst 
a UPIa peptide (lane 1), an antiserum against a UPIb peptide (lane 
2), or a combination  of  these two antisera (lane 3). Note the slightly 
slower electrophoretic mobility of UPlb than UPIa. (b) Immune- 
blotting of bovine uroplakins treated with buffer alone (lanes 1 and 
4 ) or with endoglycosidase  H (  +H; lanes 2 and 5 ) or N-glycosidase 
F (+P,, lanes 3 and 6) using anti-UPIa antiserum (lanes 1 to 3) or 
anti-UPIb antiserum (lanes 4 to 6). Note that under this nonreduc- 
ing condition a significant  amount of  the UPIa (but not UPIb) exists 
as a disulfide-crosslinked  homodimer (see text), and that the elec- 
trophoretic mobilities of both UPIa and UPIb  increased as a result 
of deglycosyladon. (c) Immunoblotting of non-reduced (lane 1) 
versus reduced (+R; lane 2) uroplakin Ia. M and D denote mono- 
mer and dimer of UPIa, respectively. 
Figure 9. Umthelium-specific 
distribution of UPIa and UPIb 
messenger RNAs. a to c show 
Northern  blot  analyses  of 
RNAs from different tissues 
and cultured cells, all of bo- 
vine origin unless noted other- 
wise.  Total RNAs (20  ~g) 
from bladder epithelium (lane 
1),  cultured  urothelial cells 
(lane 2),  esophageal epithe- 
lium (lane 3),  snout epithe- 
lium (lane 4),  intestinal epi- 
thelium (lane 5),  liver (lane 
6), kidney (lane 7), lung (lane 
8),  and brain (lane 9) were 
fractionated on a 1% agarose 
gel containing formaldehyde, 
transferred onto a nylon filter, 
and hybridized with UPIa (a), 
UPIb (b)  or human  ~-actin 
cDNA (c). 
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with members of a family of proteins all containing 4TM domains. 
The amino acid sequences of 15 related proteins are aligned by the 
method of Pearson and Lipman (1988). Dots indicate gaps intro- 
duced to maximize the alignment. The amino acids that are identi- 
cal or substitution conserved in at least nine proteins are highlighted 
in black boxes. Amino acids in one of  the following  parentheses are 
considered as substitution conserved: (E and D), (K, R, and H), 
(L L, M, and V), (F,, W, and Y), (S and T), and (A and G). Four 
potential transmembrane domains are marked TM1 to TM4, which 
are defined according to the hydropathy plot of UPIa (Figs. 4 and 
6).  The three  highly  conserved  cysteine-containing motifs are 
marked by asterisks. The proteins presented here are  (the total 
number of  amino acid residues present in each polypeptide is shown 
in parentheses): T/-1 (260 amino acids; Kallin et al., 1992); SM23 
and  SJ23 (218 amino acids; Wright et al.,  1990; Davern et al., 
1991); CD63 or ME491  (238 amino acids; Hotta et al., 1988; Met- 
zelaar et al., 1991);  A/5 (244 amino acids; Emi et al., 1993); CD9 
(228 amino acids; Lanza et al., 1991); TAPA-1 (236 amino acids; 
Oren et al., 1990); C0-029 (237 amino acids; Szala et al., 1990); 
CD37 (281 amino acids; Classon et al.,  1990); R2 (267 amino 
acids; Gaugitsch et al.,  1991); CD53 (219 amino acids; Amiot, 
1990); RDS or peripherin (346 amino acids; Travis et al.,  1991); 
and  ROM-1  (351 amino  acids;  Bascom  et  al.,  1992). The 
hydrophilic loops interconnecting the TMD2/TMD3 of RDS and 
ROM-1 (denoted by "--') are much longer than those of other pro- 
teins. Although it may not be apparent here, the sequences of UPIa 
and UPIb/TI-1 are much more similar to each other than to other 
members of the family. 
1990). This protein is recognized specifically by an antise- 
rum against a peptide synthesized according to the eDNA- 
deduced amino acid sequence of UPIa (Fig. 8 a, lane/). The 
fact that this antiserum reacts specifically with UPIa con- 
firms the validity of the corresponding eDNA sequence, and 
proves that  UPIa  and  UPIb  are  immunologically distinct 
(Fig.  8 a).  Since this anti-UPIa antiserum does not work 
well for EM localization, we do not yet have formal proof 
that UPIa is AUM associated in situ.  However, given the 
facts that UPIa is present in significant amounts in highly 
purified AUMs (Fig. 8 a) and that the closely related UPIb 
has been shown to be AUM associated (see below), there is 
little doubt that UPIa is a major subunit of AUM. We have 
recently demonstrated that the antisera against bovine UPIa 
can crossreact with a similar 25-to 27-kD AUM protein of 
a number of  mammalian species, suggesting that this protein 
is highly conserved during mammalian evolution (Wu et al., 
1994). 
The eDNA-deduced amino acid sequence of uroplakin Ib 
can account for one of the two NH2-terminal  sequences, 
i.e., '(M)AKDDSTVRCFQGLLIFGNVI', of the 27- to 28- 
kD AUM component (compare the NH2-terminal sequence 
of UPIb shown in Fig. 5 with sequence #5 of Fig. 2 A). Since 
none of  the members of  the 4TM superfamily, to which UPIa 
and  UPIb  belong  (see  below),  is  known  to  have  a  pre- 
sequence, this result strongly suggests that methionine of the 
above sequence is the translation-initiation site. The calcu- 
lated molecular mass of UPIb according to the eDNA se- 
quence is 29,677 D (Fig. 5) which, together with ,,o2 kD cor- 
responding to the high mannose-type oligosaccharides (Fig. 
8  b),  yields a  theoretical mass  of ,,o 32 kD.  This is  again 
significantly higher than the SDS-PAGE-determined value 
of 28 kD (Fig. 8 a). An antiserum raised against a synthetic 
peptide corresponding to the NH2 terminus of UPIb reacts 
specifically with  the  28-kD  UPIb  without  cross-reacting 
with the 27 kD UPIa (Fig. 8 a), thus confirming that these 
two uroplakins are distinct. In addition, we have shown re- 
cently that an affnity-pufified polyclonal antiserum, which 
was originally raised against total 27- to 28-kD UPI polypep- 
tides and used to prove the AUM association of "UPI" epi- 
topes  (Wu  et  al.,  1990),  is  monospecific for  UPIb  (Wu 
et al.,  1994). This explains why the screening of an expres- 
sion library using this polyclonal antiserum yielded a UPIb 
clone (Fig. 5). With the above and several other antisera pre- 
pared against synthetic peptides, we have recently shown that 
UPIb is present in AUMs of nine different mammalian spe- 
cies indicating that  UPIb,  like UPIa,  is conserved during 
mammalian evolution (Wu, X.-R., manuscript submitted for 
publication). 
While UPIa and UPIb can account for many important 
features of the 27- to 28-kD AUM component, they cannot 
account for the second NH2-terminal sequence of the 27- to 
28-kD component (sequence #5 of Fig. 2 A). By subtracting 
the NH2-terminal sequence of UPIb from the NH2-terminal 
sequences of the 27- to 28-kD component, we can deduce a 
second  sequence:  DF?I?WLSGLLSPVMTEL?L. Interest- 
ingly, we found that this sequence was identical to the pre- 
dominant NH2-terminal sequence of the 27 kD, AE31 anti- 
gen (data not shown). Moreover, we found recently that the 
AE31 antigen can be deglycosylated by endoglycosidase H 
giving rise to a 19-kD core protein (Lin, J.-H., and T.-T. Sun, 
unpublished results), which is much smaller than the 25-kD 
core protein of UPIa, and the 26-kD core protein of UPIb. 
Our earlier EM-localization studies showed that this AE31 
antigen,  like UPIb,  is AUM-associated in  situ  (Yu et al., 
1990). Work is in progress to further characterize this third 
uroplakin I species (uroplakin Ic; see Table I). 
The stoichiometry of the above three uroplakin I  mole- 
cules cannot be assessed accurately at the present time due 
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sional gel electrophoreses (Fig.  8 a;  and Yu et al.,  1990). 
However, the fact that all six internal amino acid sequences 
derived from the two major cyanogen bromide and two major 
tryptic peptides of the 27- to 28-kD protein (Fig.  2) came 
from UPIa suggests that this is the predominant species. That 
the NH2-terminal sequence of UPIa was not among the two 
experimentally determined raises the possibility that UPIa 
may be N blocked. 
UPIa and UPIb Belong to a Family of  Four 
Transmembrane Domain Proteins 
A comparison of the amino acid sequences of UPIa and UPIb 
with those in the GenBank revealed that the UPIb sequence 
is 93 % identical to a hypothetical protein encoded by the TI-1 
gene of a mink lung epithelial cell line (CCL64).  Kallin et 
al.  (1992)  cloned  the  cDNA  of this  gene  by differential 
screening of a cDNA library of growth-arrested cells, and 
showed that the mRNA level of TI-1 is higher in cells growth 
arrested by serum starvation.  The high degree of sequence 
identity strongly suggests that TI-1 is the mink homologue 
of bovine uroplakin Ib.  That this particular  lung epithelial 
cell line can express uroplakin Ib is intriguing  since so far 
we have not been able to detect UPIb in bovine lung by irn- 
munohistochemical  staining  or by Northern  blot analysis 
(Fig.  9;  and  unpublished  results).  More  experiments  are 
needed to determine whether CCL64 cells originate from a 
subpopulation  of UPIb/TI-l-positive  mink  lung  epithelial 
cells. In any case, the fact that TI-1 mRNA level increases 
in growth-arrested CCL64 cells (KaUin et al.,  1992) paral- 
lels  our  observation  that  in  bovine  urothelial  culture,  in 
which cells form stratified and differentiating colonies, uro- 
plakin  synthesis occurs mainly in terminally  differentiated 
cells (Surya et al.,  1990; Yu et al.,  1990,  1992). This raises 
the possibility that the uroplakin Ib/TI-1 protein is synthe- 
sized as a differentiation product in certain  lung epithelial 
cells. 
Computer  search  of the  GenBank  also established  that 
UPIa and UPIb/TI-1, which are significantly homologous to 
each other (Fig. 6), belong to a growing family of integral 
membrane  proteins  that  possess  four transmembrane  do- 
mains (Fig.  10; also see KaUin et al.,  1992, who first noted 
that TI-1  belongs to this  family).  Members of this family 
(reviewed by Horejsi and Vlcek, 1991) contain four potential 
transmembrane  domains,  of which three are located in the 
NH2-terminal portion and the fourth is near the COOH ter- 
minus (Figs. 6 and 10). The intron/exon locations of several 
members of this gene family,  including  bovine UPIa,  are 
highly conserved (Wright et al.,  1993; Lin, J.-H., and T.-T. 
Sun, manuscript in preparation).  The amino acid sequences 
of the TMDs, particularly the first three, are moderately con- 
served (Fig.  10). In addition, the major hydrophilic loop in- 
terconnecting the third and fourth TMDs of all these proteins 
share  several highly  conserved cysteine-containing  motifs 
(Fig.  10).  One of them,  CCGXXXXXDW,  appears  to be 
highly  specific for the 4TM family.  Although ROM-1 and 
RDS/peripherin,  two  retina-specific  membrane  proteins, 
also have four TMDs and their second luminal loops also 
have this particular motif (Travis et al.,  1991; Bascom et al., 
1992), they do not belong to the 4TM family because the in- 
tron/exon locations of their genes (Bascom et al.,  1993) are 
clearly distinct from the common pattern shared by the genes 
of the 4TM family (Wright et al.,  1993; Lin, J.-H., and T.-T. 
Sun,  in  preparation).  Another  highly  conserved  motif is 
PXXC.  Although  the  P  of this  motif is  missing  in  CD9, 
TAPA-1 and R2, this appears to be compensated by a proline 
residue located on the COOH-terminal  side of the cysteine 
(Fig.  10).  This suggests that the association of this cysteine 
with a proline-induced bend in the polypeptide backbone is 
critically important. It is thus curious as to why CD37 lacks 
this cysteine altogether. Finally, a GC motif exists toward the 
COOH-terminal  and of the major luminal loop (Fig.  10). 
The members of this 4TM family include, in addition to 
UPIa and UPIb, ME491/CD63,  a melanoma- and activated 
platelet-associated surface antigen (Hotta et al.,  1988; Met- 
zelaar et al.,  1991);  A15,  a hypothetical protein whose ex- 
pression  is  elevated in  activated  T  cell lines  (Emi  et al., 
1993); CD9, a surface antigen expressed by a variety ofhe- 
matopoietic  and  epithelial  cells  (Boucheix  et  al.,  1991; 
Lanza et al.,  1991);  TAPA-1, a cell surface protein present 
in many human cell lines (Oren et al., 1990); CO-029, agly- 
coprotein of gastric, colon, and renal carcinoma (Szala et al., 
1990); CD37, a glycoprotein abundantly expressed in B lym- 
phocytes (Classon et al.,  1990); R2, a membrane protein of 
activated lymphocytes (Gaugitsch et al.,  1991); CD53, a cell 
surface glycoprotein of panleukocytes (Amiot,  1990); and 
even SM23 and SJ23, two surface antigens of Schistosoma 
(Wright et al.,  1990;  Davern et al.,  1991).  The biological 
significance of this 4TM family is currently unclear.  It has 
been  shown,  however,  that  the  expression  of some of its 
members varies depending on cellular growth and differenti- 
ation (Gaugitsch et al.,  1991; Kallin et al.,  1992; Nishikata 
et al., 1992; Emi et al., 1993), and that monoclonal antibod- 
ies  to  some  of these  proteins  can  modulate  cell  growth 
(TAPA-1; Oren et al.,  1990) or adhesion (CD9; Masellis et 
al.,  1990). In this regard,  UPIa and UPIb/TI-1 are unique 
in that they are exceptionally tissue restricted, being synthe- 
sized as the major differentiation products of the urothelium 
(Fig. 9). Moreover, as a part of the uroplakin protein com- 
plex, they can be prepared readily in a naturally occurring, 
crystalline  state  in  milligram  quantities  thus  providing 
unique opportunities for detailed structural analyses (walz, 
T., X.-R. Wu, T.-T. Sun and U. Aebi, manuscript in prepara- 
tion). The fact that uroplakin I molecules apparently interact 
tightly with a smaller molecular weight uroplakin 1I of 15 kD 
is of particnlar interest, in that two other 4TM family mem- 
bers are known to share this feature. Thus CD9 can associate 
with  a  14.5-kD diphtheria  toxin receptor resulting  in en- 
hanced ligand binding (Mitamura et al.,  1992). The TAPA-1 
interacts with a 16-kD leu-13 protein to form a complex pos- 
sibly involved in signal transduction (Takahashi et al., 1990; 
Bradbury et al.,  1992). Whether other members of the 4TM 
family also interact with a protein of 14 to 15 kD is unknown. 
Transmembrane Topology of Uroplakins la and Ib 
Our data on the proteolytic digestion of UPIa inserted  in 
vitro into dog pancreatic microsomes strongly suggest that 
the two hydrophilic  loops of UPIa face the luminal  space 
(Figs. 7 and 11). The transmembrane topology of the struc- 
turally related UPIb is almost certainly the same. This topol- 
ogy is supported by the fact that the single N-glycosylation 
site located in the major hydrophilic loop of UPIa and UPIb 
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EM localization data showing that an affinity-purified  anti- 
UPIb antiserum labeled exclusively the outer leaflet of  apical 
AUM plaques (Wu et al., 1990).  Additional support for this 
interpretation came from earlier  studies on several other 
members of the 4TM family. Levy et al. (1991) studied the 
protease  susceptibility  of TAPA-1 inserted  in  vitro  into 
microsomes and showed that its two hydrophilic loops are 
protected. Tomiinson et ai. (1993) showed more recently that 
monoclonal antibodies  to  the  major  hydrophilic loop  of 
CD53 can recognize the antigen of living cells. These results 
are consistent with ours and suggest that the transmembrane 
topology of all members of the 4TM family is likely to be 
the same. 
We have previously shown that bovine uroplakin II is syn- 
thesized as a 28-kD precursor containing a cleavable signal 
peptide as well as a relatively long and heavily glycosylated 
pro-sequence (Linet al.,  1994).  The mature uroplakin II is 
100-amino acid residues long containing a single potential 
transmembrane domain located at its very COOH-terminus. 
Proteolytic digestion of in vitro translated/transcribed UPII 
that has been inserted into dog pancreatic microsomes indi- 
cates that the NH2-terminal bulk of the UPII molecule is lo- 
cated on the luminal side (type I topology; Linet al., 1994, 
Fig.  11). Molecular characterization of the 47-kD  bovine 
uroplakin HI has established that it is also a type I protein 
containing a single transmembrane domain and assuming an 
N~o/C~to configuration (Wu and Sun, 1993).  Moreover, our 
data indicate that, of all the major AUM components, UPIH 
is the only one having a significant  cytoplasmic domain. This 
domain contains multiple, potential phosphorylation sites, 
which can potentially be involved in regulating AUM/cyto- 
skeletal interaction (Fig.  11; Wu and Sun,  1993). 
Thus, an important feature shared by all major uroplakins 
(Fig. 11) is that they all have large exoplasmic domains with 
very small cytoplasmic ones. This is true for UPIa, UPIb, 
and UPII (Fig. 11). Even for UPm, the mass of its exoplas- 
mic domain (17-kD core protein plus 20-kD equivalents of 
oligosaccharides) greatly exceeds its cytoplasmic one (~5- 
kD).  Since these four uroplakins (UPIa, UPIb,  UPII, and 
UPHI) can account for >90% of the total proteins of highiy 
purified AUMs exhibiting crystalline patches of 12-rim parti- 
cles, it seems clear that the extracellular domains of some 
of these major AUM subunits must form the bulk of such 
exoplasmic particles. The exceedingly high ratio of exoplas- 
mic vs. cytoplasmic domains of uroplakins provides a possi- 
ble explanation for the observation that the 12-nm protein 
particles are  associated exclusively with the outer  leaflet 
(Robertson and Vergara,  1980;  Brisson and Wade,  1983; 
Taylor and Robertson,  1984). 
The Major Luminal Loop of Uroplakin Ia Is Stabilized 
by Intramolecular Disulfide Bonds 
As mentioned earlier, the major hydrophilic loop of all mem- 
bers of the 4TM proteins contain several highly conserved 
cysteine residues.  Several pieces of evidence suggest that 
some of these residues are involved in forming intramolecu- 
lar disulfide  bridges. Oligino et al. (1988) showed that an epi- 
tope in the major loop of SM23 is destroyed by reduction. 
Levy et ai.  (1991) showed that a  monoclonal antibody to 
TAPA-1 fails to  recognize  in  vitro  transcribed/translated 
TAPA-1 unless it is inserted into dog pancreatic microsomes. 
Figure 11. The hypothetical  transmembrane  topology of Umplakins 
Ia, Ib, II, and Ill. The transmembrane topology of UPIa and UPIb 
is based on data shown in Figs. 4, 5, 6, and 7, while that of UPII 
and UPIH is based on Lin et al. (1994) and Wu and Sun (1993), 
respectively. The potential transmembrane  domains (TMD) of uro- 
plakins are represented by thick vertical bars. N and C denote the 
NH2 and COOH terminus, respectively,  of the proteins. The lipid 
bilayer is represented by the two horizontal bars, with its luminal 
(lum) and cytoplasmic (cyto) leaflets labeled. The positively and 
negatively charged amino acid residues are represented by filled 
and gray circles. Filled boxes denote potential N-glycosylation 
sites. Note that accordin~  to this hypothetical scheme UPIa, UPIb, 
and UPII have practically no cytoplasmic domains, and that even 
for UPIII its extracellular domain greatly exceeds its cytoplasmic 
domain (which may be involved  in AUM/cytoskeletal  interaction; 
see Wu and Sun, 1993). 
In addition, intramolecular disulfide bond(s) is (are) impor- 
tant for maintaining its antigenicity. Tomlinson et ai. (1993) 
also showed that monoclonal antibodies to an epitope of the 
hydrophilic loop of rat CD53 antigen is sensitive to reduc- 
tion/alkylation. 
One of the two major cyanogen bromide products of the 
27- to 28-kD UPI component (C2, see Fig. I a, lane 4) con- 
tained two NI-I2-terminal sequences (Nos. 3 and 1; Figs. 2 
B  and  4)  which  correspond  to  a  1.2-kD  peptide  [IE- 
QECCGTSGPM] and a  '~7.6-kD  peptide located immedi- 
ately downstream [DWVNFTSAF...  GPAILM]. The co- 
electrophoresis of these two peptides of greatly different size 
during SDS-PAGE under a non-reducing condition suggests 
that they are disulfide cross-linked. While in peptide No. 3 
the doublet CC are the only cysteines that can be involved 
in this cross-linking,  more data are needed to determine 
which of the four cysteines in peptide No. 1 is cross-linked. 
Concluding Remarks 
Although  proteins  moderately  homologous  to  UPIa  and 
UPIb are widespread, only urothelium makes the character- 
istic crystalline arrays of 12-nm protein particles. Since the 
sequences of the luminal loops of UPIa and Ib are quite dis- 
tinct from those of the other 4TM family members, these 
UPI sequences may be involved in interacting specifically 
with the UPH and UPI~ to form the AUM particles. As one 
of the approaches to study these interactions in detail, we 
have generated a panel of rabbit and chicken antisera against 
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derived amino acid sequences of not only UPIa and UPIb 
(Fig.  8), but also uroplakin  II (Lin et al.,  1994) and uro- 
plakin HI (Wu and Sun, 1993). Immunolocalization of these 
epitopes on purified AUMs coupled with digital image anal- 
ysis may allow us to assign specific epitopes to individual 
domains of the 12-rim protein particles. 
The function of uroplakins in general,  and of uroplakin I 
isoforms in particular, has not yet been firmly established. 
However, the fact that UPIa and UPIb are highly conserved 
during mammalian evolution, both in terms of their size and 
epitopes (Wu et al., 1994), suggests that they play an impor- 
tant role in normal bladder epithelial  physiology-possibly 
in regulating membrane permeability of superficial umbrella 
cells or in stabilizing  the apical membrane through AUM/ 
cytoskeletal interactions. Experiments are in progress to bet- 
ter understand how UPI molecules interact with other uro- 
plakins to form the 12-nm protein particles,  and to eventu- 
ally understand  the functional  role of various uroplakin  I 
molecules by gene targeting and other transgenic approaches. 
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